<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".07" citation="COMAR 10.34.35.07" title_num="10" subtitle_num="34" chapter_num="35" heading="Training Requirements.">
  <paragraph num="A.">
    <text>Personnel shall be trained in the following areas where appropriate:</text>
    <paragraph num="(1)">
      <text>Patient rights and responsibilities;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Patient safety;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Performance improvement program;</text>
    </paragraph>
    <paragraph num="(4)">
      <text>Universal precautions which are incorporated by reference in COMAR 10.06.01.01-1;</text>
    </paragraph>
    <paragraph num="(5)">
      <text>Warehouse and equipment orientation;</text>
    </paragraph>
    <paragraph num="(6)">
      <text>Waste management;</text>
    </paragraph>
    <paragraph num="(7)">
      <text>Handling hazardous substances;</text>
    </paragraph>
    <paragraph num="(8)">
      <text>Policies and procedures;</text>
    </paragraph>
    <paragraph num="(9)">
      <text>Recognizing signs of patient abuse and neglect;</text>
    </paragraph>
    <paragraph num="(10)">
      <text>Recognizing signs of IV drug abuse;</text>
    </paragraph>
    <paragraph num="(11)">
      <text>Customer service and cultural sensitivity training;</text>
    </paragraph>
    <paragraph num="(12)">
      <text>Emergency policies and procedures which support the continuum of patient care during natural or manmade disasters; and</text>
    </paragraph>
    <paragraph num="(13)">
      <text>Patient confidentiality and the Health Insurance Portability and Accountability Act, 45 CFR Parts 160 and 164.</text>
    </paragraph>
  </paragraph>
  <paragraph num="B.">
    <text>A pharmacist shall be trained and evaluated in the following areas, including but not limited to:</text>
    <paragraph num="(1)">
      <text>Clinical management of therapies and disease states managed by the infusion pharmacy services, including but not limited to:</text>
      <paragraph num="(a)">
        <text>Specific dosing and monitoring protocols;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Care planning;</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Lab value ranges; and</text>
      </paragraph>
      <paragraph num="(d)">
        <text>Side effects;</text>
      </paragraph>
    </paragraph>
    <paragraph num="(2)">
      <text>Pump use and programming;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Parenteral infusion access devices and therapy-specific appropriateness by device;</text>
    </paragraph>
    <paragraph num="(4)">
      <text>Supplies by therapy and device;</text>
    </paragraph>
    <paragraph num="(5)">
      <text>Accurate set-up of compounding worksheet instructions;</text>
    </paragraph>
    <paragraph num="(6)">
      <text>Pharmacist functions on computer systems;</text>
    </paragraph>
    <paragraph num="(7)">
      <text>Documentation;</text>
    </paragraph>
    <paragraph num="(8)">
      <text>If performing sterile compounding, COMAR 10.34.19;</text>
    </paragraph>
    <paragraph num="(9)">
      <text>Medication storage;</text>
    </paragraph>
    <paragraph num="(10)">
      <text>IV compatibility and stability;</text>
    </paragraph>
    <paragraph num="(11)">
      <text>Calculations to ensure:</text>
      <paragraph num="(a)">
        <text>IV dose appropriateness; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Compounding accuracy, if applicable; and</text>
      </paragraph>
    </paragraph>
    <paragraph num="(12)">
      <text>On-call requirements and procedures for handling after-hours care.</text>
    </paragraph>
  </paragraph>
  <paragraph num="C.">
    <text>A pharmacy technician obtaining clinical information shall be trained and evaluated in the following areas, including but not limited to:</text>
    <paragraph num="(1)">
      <text>Pharmacy technician functions on computer systems;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Parenteral infusion access devices</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Supplies specific to therapy and device</text>
    </paragraph>
    <paragraph num="(4)">
      <text>Storage and shipping protocols;</text>
    </paragraph>
    <paragraph num="(5)">
      <text>Pharmaceutical calculations for IV compounding, if applicable;</text>
    </paragraph>
    <paragraph num="(6)">
      <text>Patient triage forms — therapy-specific training and communication with the pharmacist as specified in Regulation .05A(3)(a) of this chapter; and</text>
    </paragraph>
    <paragraph num="(7)">
      <text>Documentation of:</text>
      <paragraph num="(a)">
        <text>Communication with patients or caregiver; and</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Delivery scheduling.</text>
      </paragraph>
    </paragraph>
  </paragraph>
  <paragraph num="D.">
    <text>Unlicensed personnel shall be trained and evaluated in the following areas as applicable:</text>
    <paragraph num="(1)">
      <text>Insurance pre-authorization;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Billing;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Delivery procedures;</text>
    </paragraph>
    <paragraph num="(4)">
      <text>Supplies;</text>
    </paragraph>
    <paragraph num="(5)">
      <text>Picking and packing of supplies;</text>
    </paragraph>
    <paragraph num="(6)">
      <text>Drug storage;</text>
    </paragraph>
    <paragraph num="(7)">
      <text>Shipping protocols; and</text>
    </paragraph>
    <paragraph num="(8)">
      <text>Cleaning, testing, and maintenance of patient-use equipment according to manufacturers’ specifications.</text>
    </paragraph>
  </paragraph>
</regulation>